Contents

Current Pharmaceutical Design, Volume 12 - Number 22

Editorial [ Adhesion Molecules and Drug Targeting Executive Editor: Seetharama D.S. Jois ]

, 12(22): 2721 - 2722

Seetharama D.S. Jois


DOI: 10.2174/138161206777947687




Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting

, 12(22): 2723 - 2747

A. Meyer, J. Auernheimer, A. Modlinger and H. Kessler


DOI: 10.2174/138161206777947740




Integrins in Drug Targeting-RGD Templates in Toxins

, 12(22): 2749 - 2769

X. Lu, D. Lu, M. F. Scully and V. V. Kakkar


DOI: 10.2174/138161206777947713




LFA-1 as a Key Regulator of Immune Function: Approaches toward the Development of LFA-1-Based Therapeutics

, 12(22): 2771 - 2795

P. A. Giblin and R. M. Lemieux


DOI: 10.2174/138161206777947731




Targeting T-Cell Adhesion Molecules for Drug Design

, 12(22): 2797 - 2812

Seetharama D.S. Jois, Liu Jining and Latha M. Nagarajarao


DOI: 10.2174/138161206777947696




Structure and Function of the Intercellular Junctions: Barrier of Paracellular Drug Delivery

, 12(22): 2813 - 2824

Kai Zheng, Maulik Trivedi and Teruna J. Siahaan


DOI: 10.2174/138161206777947722




Leukocyte Adhesion: A Suitable Target for Anti-Inflammatory Drugs

, 12(22): 2825 - 2831

Ulrich Mrowietz and Wolf-Henning Boehncke


DOI: 10.2174/138161206777947768




Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting

, 12(22): 2833 - 2848

Mary A. Bewick and Robert M. Lafrenie


DOI: 10.2174/138161206777947704




Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases

, 12(22): 2849 - 2861

Konstantinos N. Syrigos and Anastasios J. Karayiannakis


DOI: 10.2174/138161206777947759




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science